Source:http://linkedlifedata.com/resource/pubmed/id/19118520
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2009-1-28
|
pubmed:abstractText |
REG (Regenerating gene) Ialpha protein functions as a growth factor for gastrointestinal cancer cells, and its mRNA expression is strongly associated with a poor prognosis in gastrointestinal cancer patients. We here demonstrated that PPARgamma-agonist thiazolidinediones (TZDs) inhibited cell proliferation and REG Ialpha protein/mRNA expression in gastrointestinal cancer cells. TZDs inhibited the REG Ialpha gene promoter activity, via its cis-acting element which lacked PPAR response element and could not bind to PPARgamma, in PPARgamma-expressing gastrointestinal cancer cells. The inhibition was reversed by co-treatment with a specific PPARgamma-antagonist GW9662. Although TZDs did not inhibit the REG Ialpha gene promoter activity in PPARgamma-non-expressing cells, PPARgamma overexpression in the cells recovered their inhibitory effect. Taken together, TZDs inhibit REG Ialpha gene transcription through a PPARgamma-dependent pathway. The TZD-induced REG Ialpha mRNA reduction was abolished by cycloheximide, indicating the necessity of novel protein(s) synthesis. TZDs may therefore be a candidate for novel anti-cancer drugs for patients with gastrointestinal cancer expressing both REG Ialpha and PPARgamma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Lithostathine,
http://linkedlifedata.com/resource/pubmed/chemical/PPAR gamma,
http://linkedlifedata.com/resource/pubmed/chemical/REG1A protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1090-2104
|
pubmed:author |
pubmed-author:IkedaTakayukiT,
pubmed-author:NataKojiK,
pubmed-author:NoguchiNaoyaN,
pubmed-author:OkamotoHiroshiH,
pubmed-author:ShervaniNausheen JNJ,
pubmed-author:SugawaraAkiraA,
pubmed-author:SuzukiIwaoI,
pubmed-author:TakahashiIwaoI,
pubmed-author:TakasawaShinS,
pubmed-author:UnnoMichiakiM,
pubmed-author:UrunoAkiraA,
pubmed-author:YamauchiAkiyoA,
pubmed-author:YoshikawaTakeoT
|
pubmed:issnType |
Electronic
|
pubmed:day |
13
|
pubmed:volume |
379
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
743-8
|
pubmed:meshHeading |
pubmed-meshheading:19118520-Base Sequence,
pubmed-meshheading:19118520-Cell Line, Tumor,
pubmed-meshheading:19118520-Cell Proliferation,
pubmed-meshheading:19118520-Gastrointestinal Neoplasms,
pubmed-meshheading:19118520-Humans,
pubmed-meshheading:19118520-Lithostathine,
pubmed-meshheading:19118520-PPAR gamma,
pubmed-meshheading:19118520-Promoter Regions, Genetic,
pubmed-meshheading:19118520-RNA, Messenger,
pubmed-meshheading:19118520-Thiazolidinediones,
pubmed-meshheading:19118520-Transcription, Genetic
|
pubmed:year |
2009
|
pubmed:articleTitle |
Thiazolidinediones inhibit REG Ialpha gene transcription in gastrointestinal cancer cells.
|
pubmed:affiliation |
Department of Advanced Biological Sciences for Regeneration, Kotobiken Medical Laboratories, Tohoku University Graduate School of Medicine, Sendai, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|